MX2023008317A - Anticuerpo anti tau fosforilada en la treonina 217 (pt217). - Google Patents
Anticuerpo anti tau fosforilada en la treonina 217 (pt217).Info
- Publication number
- MX2023008317A MX2023008317A MX2023008317A MX2023008317A MX2023008317A MX 2023008317 A MX2023008317 A MX 2023008317A MX 2023008317 A MX2023008317 A MX 2023008317A MX 2023008317 A MX2023008317 A MX 2023008317A MX 2023008317 A MX2023008317 A MX 2023008317A
- Authority
- MX
- Mexico
- Prior art keywords
- tau antibody
- tau
- antibody
- disclosed
- binding fragment
- Prior art date
Links
- 239000012634 fragment Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se da a conocer en el presente documento un anticuerpo anti-pT217 Tau o un fragmento de unión a pT217 Tau del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163151254P | 2021-02-19 | 2021-02-19 | |
| PCT/JP2022/006458 WO2022176959A1 (en) | 2021-02-19 | 2022-02-17 | Anti-pt217 tau antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023008317A true MX2023008317A (es) | 2023-07-24 |
Family
ID=82930689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023008317A MX2023008317A (es) | 2021-02-19 | 2022-02-17 | Anticuerpo anti tau fosforilada en la treonina 217 (pt217). |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240076361A1 (es) |
| EP (1) | EP4259801A1 (es) |
| JP (1) | JP2024509683A (es) |
| KR (1) | KR20230147034A (es) |
| CN (1) | CN116635414A (es) |
| AU (1) | AU2022222134A1 (es) |
| BR (1) | BR112023014151A2 (es) |
| CA (1) | CA3203800A1 (es) |
| IL (1) | IL304154A (es) |
| MX (1) | MX2023008317A (es) |
| TW (1) | TW202246321A (es) |
| WO (1) | WO2022176959A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY183989A (en) * | 2011-09-19 | 2021-03-17 | Axon Neuroscience Se | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| JOP20180021A1 (ar) * | 2017-03-16 | 2019-01-30 | Janssen Biotech Inc | الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها |
| EA202092087A1 (ru) * | 2018-03-05 | 2020-11-17 | Янссен Фармацевтика Нв | Анализы для выявления нейродегенеративных заболеваний |
| AU2019244481A1 (en) * | 2018-03-28 | 2020-10-01 | Axon Neuroscience Se | Antibody-based methods of detecting and treating Alzheimer's disease |
-
2022
- 2022-02-17 WO PCT/JP2022/006458 patent/WO2022176959A1/en active Application Filing
- 2022-02-17 JP JP2023546039A patent/JP2024509683A/ja active Pending
- 2022-02-17 AU AU2022222134A patent/AU2022222134A1/en active Pending
- 2022-02-17 EP EP22756277.4A patent/EP4259801A1/en active Pending
- 2022-02-17 US US18/273,355 patent/US20240076361A1/en active Pending
- 2022-02-17 CA CA3203800A patent/CA3203800A1/en active Pending
- 2022-02-17 MX MX2023008317A patent/MX2023008317A/es unknown
- 2022-02-17 KR KR1020237020014A patent/KR20230147034A/ko unknown
- 2022-02-17 TW TW111105862A patent/TW202246321A/zh unknown
- 2022-02-17 CN CN202280008145.9A patent/CN116635414A/zh active Pending
- 2022-02-17 BR BR112023014151A patent/BR112023014151A2/pt unknown
-
2023
- 2023-06-29 IL IL304154A patent/IL304154A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN116635414A (zh) | 2023-08-22 |
| EP4259801A1 (en) | 2023-10-18 |
| WO2022176959A1 (en) | 2022-08-25 |
| JP2024509683A (ja) | 2024-03-05 |
| BR112023014151A2 (pt) | 2023-10-10 |
| IL304154A (en) | 2023-09-01 |
| US20240076361A1 (en) | 2024-03-07 |
| CA3203800A1 (en) | 2022-08-25 |
| TW202246321A (zh) | 2022-12-01 |
| AU2022222134A1 (en) | 2023-07-13 |
| KR20230147034A (ko) | 2023-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020000594S1 (es) | Estuche de auriculares. | |
| CA211013S (en) | Vaporizer device | |
| CL2020000596S1 (es) | Auriculares. | |
| MX2019008146A (es) | Virus alterado. | |
| MX2021009440A (es) | Anticuerpos que reconocen tau. | |
| PH12021551048A1 (en) | Antibodies recognizing tau | |
| PE20230381A1 (es) | Proteina de union a rgma | |
| AU2018448903A8 (en) | Antibodies recognizing tau | |
| MX2020011529A (es) | Un metodo para optimizar la expresion de anticuerpos. | |
| CL2019002232S1 (es) | Automóvil. | |
| EA202190822A1 (ru) | Технологии для выполнения действий на основе обнаружения объектов | |
| CL2020001201S1 (es) | Automóvil. | |
| CL2020000174S1 (es) | Automóvil. | |
| MX2023008317A (es) | Anticuerpo anti tau fosforilada en la treonina 217 (pt217). | |
| CL2020000224S1 (es) | Automóvil. | |
| CA204255S (en) | Knob | |
| CA228042S (en) | Bottle | |
| CA212928S (en) | Necklace | |
| ZA202211681B (en) | Drive element | |
| CL2019003218S1 (es) | Descorchador. | |
| CA195978S (en) | Electronic cigarette | |
| MX2022015892A (es) | Dispositivos antipatogenos y metodos de los mismos para aplicaciones antifungicas. | |
| MX2021010517A (es) | Anticuerpos que reconocen tau. | |
| MA53052A1 (es) | ||
| CL2019002348S1 (es) | Encendedores a gas. |